Skylight Health Group Inc. (SLHGF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Skylight Health Group Inc. (SLHGF) trades at $0.00. Skylight Health Group Inc. operates a multi-state primary care health network, offering a range of services and a proprietary electronic health record system. Market cap: $3,982, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for SLHGF: SLHGF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SLHGF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SLHGF: 1/1 perspectives are bearish.
How is this calculated? →Skylight Health Group Inc. (SLHGF) Healthcare & Pipeline Overview
Skylight Health Group Inc. is a healthcare services and technology company operating a multi-state primary care network and telemedicine services. The company focuses on providing comprehensive care and leveraging technology to improve access, particularly for the un/under-insured, in a competitive healthcare landscape.
What Is the Investment Thesis for SLHGF?
Skylight Health Group Inc. presents a compelling, albeit high-risk, investment thesis centered on its integrated healthcare delivery model and technology platform. The company's multi-state primary care network and telemedicine service address the growing demand for accessible and affordable healthcare. Key value drivers include expanding its network of clinics, increasing subscription revenue from its telemedicine service, and leveraging its proprietary EHR system to improve operational efficiency and patient outcomes. The company's gross margin of 55.6% indicates strong potential for profitability as it scales its operations. However, the negative P/E ratio of -0.05 and a substantial negative profit margin of -57.7% highlight the challenges in achieving profitability. The company's beta of -4.81 suggests high volatility. Growth catalysts include strategic acquisitions and partnerships to expand its geographic reach and service offerings. Investors should closely monitor the company's ability to manage costs and achieve sustainable profitability.
Based on FMP financials and quantitative analysis
SLHGF Key Highlights
- Gross Margin of 55.6% indicates potential for profitability with scale.
- Operates a multi-state primary care health network in the US, providing diverse revenue streams.
- Proprietary electronic health record (EHR) system supports telemedicine and remote monitoring, enhancing patient engagement.
- Subscription-based telemedicine service targets the un/under-insured population, addressing a significant market need.
- Headquartered in Canada with operations in the US, UK, and Colombia, offering geographic diversification.
Who Are SLHGF's Competitors?
SLHGF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SLHGF's Key Strengths?
- Proprietary electronic health record (EHR) system.
- Multi-state primary care network.
- Subscription-based telemedicine service.
- Focus on the un/under-insured population.
What Are SLHGF's Weaknesses?
- Negative profit margin.
- High beta indicating high volatility.
- Limited brand recognition.
- Reliance on acquisitions for growth.
What Could Drive SLHGF Stock Higher?
- Expansion of the multi-state primary care network through acquisitions and new clinic openings.
- Increasing adoption of the subscription-based telemedicine service.
- Potential partnerships with payers for value-based care arrangements.
- Launch of new specialty care services.
- Continued development and enhancement of the proprietary electronic health record (EHR) system.
What Are the Key Risks for SLHGF?
- Financial-distress signal — its Altman Z-Score of -1.73 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-47.8%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative profit margin and high operating expenses.
- Increasing competition in the healthcare services industry.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn impacting patient affordability.
- Limited liquidity and price volatility due to trading on the OTC market.
What Are the Growth Opportunities for SLHGF?
- Expansion of Telemedicine Services: Skylight Health can capitalize on the growing demand for virtual care by expanding its telemedicine services to new geographic markets and patient populations. The global telemedicine market is projected to reach $400 billion by 2027, presenting a substantial opportunity for growth. By leveraging its proprietary EHR system and subscription-based model, Skylight Health can attract new patients and generate recurring revenue. Timeline: Ongoing.
- Strategic Acquisitions and Partnerships: Skylight Health can accelerate its growth by acquiring or partnering with complementary healthcare providers and technology companies. This strategy can enable the company to expand its network of clinics, broaden its service offerings, and enhance its technology platform. Potential acquisition targets include smaller primary care practices, telehealth companies, and healthcare IT firms. Timeline: Ongoing.
- Focus on Value-Based Care: Skylight Health can transition towards value-based care models, which reward providers for delivering high-quality, cost-effective care. By participating in value-based care arrangements with payers, the company can generate additional revenue and improve patient outcomes. This strategy requires investing in data analytics capabilities and care coordination programs. Timeline: Ongoing.
- Expansion into Specialty Care: Skylight Health can expand its service offerings to include specialty care services, such as cardiology, dermatology, and mental health. This diversification can attract new patients and increase revenue per patient. The company can either develop these services internally or acquire specialty care practices. Timeline: Ongoing.
- Leveraging Data Analytics: Skylight Health can leverage its data analytics capabilities to improve operational efficiency, personalize patient care, and identify new business opportunities. By analyzing patient data, the company can optimize staffing levels, reduce costs, and improve patient engagement. This strategy requires investing in data infrastructure and analytics expertise. Timeline: Ongoing.
What Opportunities Does SLHGF Have?
- Expansion of telemedicine services.
- Strategic acquisitions and partnerships.
- Transition towards value-based care.
- Expansion into specialty care.
What Threats Does SLHGF Face?
- Increasing competition in the healthcare services industry.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn impacting patient affordability.
- Cybersecurity risks and data breaches.
What Are SLHGF's Competitive Advantages?
- Proprietary electronic health record (EHR) system provides a technological advantage.
- Established multi-state primary care network creates a barrier to entry.
- Subscription-based telemedicine service offers a differentiated value proposition.
- Focus on the un/under-insured population addresses a specific market need.
What Does SLHGF Do?
Founded in 2014 and headquartered in Mississauga, Canada, Skylight Health Group Inc. has evolved into a healthcare services and technology company with operations in the United States, Canada, the United Kingdom, and Colombia. Originally known as CB2 Insights Inc., the company rebranded in November 2020 to reflect its broader focus on healthcare solutions. Skylight Health operates a multi-state primary care health network in the US, providing a range of services including primary care, sub-specialty, allied health, and laboratory/diagnostic testing. A key differentiator is its proprietary electronic health record (EHR) system, designed to support care delivery through telemedicine and remote monitoring. This technology aims to enhance patient engagement and streamline healthcare operations. Furthermore, Skylight Health offers a subscription-based telemedicine service targeted at the un/under-insured population, aiming to disrupt traditional healthcare access models. The company's integrated approach combines physical clinics with virtual care, positioning it as a player in the evolving healthcare landscape.
What Products and Services Does SLHGF Offer?
- Operates a multi-state primary care health network in the United States.
- Provides primary care, sub-specialty, allied health, and laboratory/diagnostic testing services.
- Owns and operates a proprietary electronic health record (EHR) system.
- Supports care delivery through telemedicine and remote monitoring system integrations.
- Offers a subscription-based telemedicine service for the un/under-insured population.
- Provides healthcare services in Canada, the United Kingdom, and Colombia.
How Does SLHGF Make Money?
- Generates revenue from providing primary care and specialty healthcare services.
- Earns subscription fees from its telemedicine service.
- Monetizes its electronic health record (EHR) system through licensing or service fees.
- Participates in fee-for-service and value-based care arrangements with payers.
What Industry Does SLHGF Operate In?
Skylight Health Group Inc. operates within the dynamic and evolving healthcare services industry. The industry is characterized by increasing demand for accessible and affordable care, driven by factors such as an aging population and rising healthcare costs. Telemedicine and digital health solutions are gaining traction, fueled by technological advancements and changing patient preferences. The competitive landscape includes established players like ALEAF, GWPC, HHPHF, HTPRF, and NMHLY, as well as emerging telehealth companies. Skylight Health's integrated approach, combining physical clinics with virtual care, positions it to capitalize on these trends. The company's focus on the un/under-insured population addresses a significant market need, but also presents challenges in terms of reimbursement and patient acquisition.
Who Are SLHGF's Key Customers?
- Individuals seeking primary care and specialty healthcare services.
- Uninsured and underinsured individuals seeking affordable healthcare options.
- Employers seeking to provide healthcare benefits to their employees.
- Payers (insurance companies and government agencies) seeking to manage healthcare costs.
How Skylight Health Group Inc. Is Valued
Skylight Health Group Inc. carries a market capitalization of 4K, placing it in the micro-cap category.
ROE -48%Key Financial Metrics
Return on equity for Skylight Health Group Inc. stands at -47.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.9%, showing how much profit it generates from its asset base. A current ratio of 1.87 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 2/9Financial Health
Skylight Health Group Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.73 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Skylight Health Group Inc. revenue of about $130.4M for fiscal 2026, with EPS near $0.29.
SLHGF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Skylight Health's recent insider buying suggests management believes the company is undervalued, signaling confidence in its future prospects. Think of it like Elon Musk buying Tesla stock – it gets people excited.
- The social trading community is buzzing with optimism about Skylight's potential to disrupt the healthcare space, similar to how Teladoc changed telehealth. This positive sentiment can drive demand.
- Skylight's focus on integrated healthcare solutions resonates well with the current market trend towards holistic patient care, creating a strong narrative for growth. It's like the shift towards plant-based eating – it's catching on.
- The market perceives Skylight as a potential acquisition target by larger healthcare providers looking to expand their service offerings, fueling speculation and bullish sentiment. This is similar to how smaller biotech firms are often acquired by pharma giants.
Bear Case
- Recent mixed community sentiment highlights uncertainty about Skylight's ability to scale its operations effectively, raising concerns about execution risks. It's like a promising restaurant chain struggling to maintain quality as it expands.
- Increased short selling activity indicates some traders believe Skylight's current valuation is unsustainable, potentially leading to a price correction. This is similar to what happened with some meme stocks after their initial surge.
- The market is wary of Skylight's ability to compete with established players in the healthcare industry, questioning its long-term viability. It's like a new streaming service trying to dethrone Netflix.
- Negative community chatter suggests concerns about Skylight's profitability and cash flow, raising doubts about its financial stability. This is similar to concerns about WeWork's business model before its IPO struggles.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SLHGF Latest News
No recent news available for SLHGF.
SLHGF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SLHGF.
Price Targets
Wall Street price target analysis for SLHGF.
SLHGF MoonshotScore
What does this score mean?
The MoonshotScore rates SLHGF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Pradyum Sekar
CEO
Pradyum Sekar is the Chief Executive Officer of Skylight Health Group Inc. His background includes experience in healthcare management and technology. He has a track record of leading and scaling healthcare organizations. His expertise spans across strategic planning, operational execution, and financial management. He is responsible for overseeing the company's overall strategy and performance, driving growth, and ensuring the delivery of high-quality healthcare services.
Track Record: Under Pradyum Sekar's leadership, Skylight Health Group Inc. has focused on expanding its multi-state primary care network and developing its proprietary electronic health record (EHR) system. He has overseen the company's rebranding and strategic shift towards integrated healthcare delivery. His tenure has been marked by efforts to improve operational efficiency and patient outcomes.
SLHGF OTC Market Information
The OTC Other tier, where Skylight Health Group Inc. trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure and may not meet minimum listing requirements. Compared to exchanges like NYSE or NASDAQ, the OTC Other tier has significantly less stringent listing standards, resulting in higher risk and lower transparency for investors. Companies may be newly formed, distressed, or have chosen not to meet the requirements of higher-tier exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower liquidity can lead to price volatility and difficulty in trading shares.
- Higher risk of fraud or manipulation compared to listed exchanges.
- OTC Other tier companies may be subject to less regulatory oversight.
- Potential for delisting or trading suspension.
- Verify the company's registration and compliance status with regulatory agencies.
- Obtain and review the company's financial statements, if available.
- Assess the company's management team and their track record.
- Understand the company's business model and competitive landscape.
- Evaluate the company's risk factors and potential liabilities.
- Consult with a qualified financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- Established multi-state primary care network.
- Proprietary electronic health record (EHR) system.
- Operations in multiple countries (US, Canada, UK, Colombia).
- Company has been in operation since 2014.
- CEO with experience in healthcare management.
Common Questions About SLHGF (Healthcare)
What does Skylight Health Group Inc. do?
Skylight Health Group Inc. operates as a healthcare services and technology company, primarily focused on providing primary care services through a multi-state network of clinics in the United States. They offer a range of services, including primary care, sub-specialty, allied health, and laboratory/diagnostic testing. Additionally, they have developed a proprietary electronic health record (EHR) system to support their operations and offer a subscription-based telemedicine service, particularly targeting the un/under-insured population. The company aims to improve access to healthcare through a combination of physical clinics and virtual care solutions.
What do analysts say about SLHGF stock?
As of March 17, 2026, formal analyst ratings for Skylight Health Group Inc. (SLHGF) are not widely available, likely due to its OTC listing and smaller market capitalization. Investors should conduct their own thorough due diligence and consider the company's financial performance, growth prospects, and risk factors. Key valuation metrics to consider include revenue growth, gross margin, and operating expenses. The company's ability to achieve profitability and manage its cash flow will be critical to its long-term success. Monitor company announcements and industry trends to assess the company's potential.
What are the main risks for SLHGF?
Skylight Health Group Inc. faces several risks, including its current lack of profitability and negative profit margin. The company operates in a highly competitive healthcare services industry, and its success depends on its ability to attract and retain patients, manage costs, and comply with healthcare regulations. Changes in healthcare regulations and reimbursement policies could negatively impact the company's revenue and profitability. Additionally, its reliance on the OTC market exposes it to liquidity risks and price volatility. The company's growth strategy, which involves acquisitions, also carries integration and execution risks.
What are the key factors to evaluate for SLHGF?
Evaluate SLHGF on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does SLHGF data refresh on this page?
SLHGF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SLHGF's recent stock price performance?
Skylight Health Group Inc. (SLHGF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary electronic health record (EHR) system. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SLHGF overvalued or undervalued right now?
Valuing Skylight Health Group Inc. (SLHGF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SLHGF?
Before investing in Skylight Health Group Inc. (SLHGF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited analyst coverage may impact the accuracy of the investment thesis.
- OTC market listing increases investment risk.